Search

Denotivir

Denotivir is a small molecule drug. The usage of the INN stem '-vir' in the name indicates that Denotivir is a antiviral. Denotivir has a monoisotopic molecular weight of 371.05 Da.

Osaterone

Osaterone is a small molecule drug. The usage of the INN stem '-terone' in the name indicates that Osaterone is a antiandrogen. Osaterone has a monoisotopic molecular weight of 364.14 Da.

Sinitrodil

Sinitrodil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Sinitrodil is a vasodilator. Sinitrodil has a monoisotopic molecular weight of 238.06 Da.

Patiromer

Patiromer is a powder for suspension in water for oral administration, approved in the U.S. as Veltassa in October, 2015. … Patiromer sorbitex calcium is an amorphous, free-flowing powder that is composed of individual spherical beads.

Lutetium Lu-177 vipivotide tetraxetan

Lutetium Lu-177 vipivotide tetraxetan is a radioligand therapeutic agent. … [L41290] In October 2022, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended lutetium Lu-177 vipivotide tetraxetan be granted marketing authorization for the treatment of prostate

Denosumab

It is the first and currently the only RANKL inhibitor approved to prevent osteoclast-mediated bone loss. … Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption via inhibiting RANK-mediated activation of

Meloxicam

It is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy.[A190198,A190201] … [A190189] With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations.

Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen

Metergoline

Metergoline is an ergot-derived psychoactive drug that acts as a ligand for serotonin and dopamine receptors. … [A27181] Its use has been studied in various clinical settings such as a treatment for seasonal affective disorder, prolactin hormone regulation due to its inhibitory effect on prolactin release,[A27182

Inavolisib

[A264563] Chemotherapeutic agents targeting the PI3K p110α catalytic subunit have shown antitumor activity and a manageable safety profile - some of which are in clinical use, like [alpelisib] - but preclinical … _PIK3CA_ is one of the most frequently mutated oncogenes, with the resulting mutated p110α protein it encodes playing a central role in tumor cell proliferation.